Bladder Cancer - Results from #140

Treatment Options and Outcomes in Nonmetastatic Muscle Invasive Bladder Cancer. July 22, 2019

Integrative Analysis of Genomic and Clinical Data Reveals Intrinsic Characteristics of Bladder Urothelial Carcinoma Progression. July 19, 2019

A Pre-operative Nomogram for Prediction of Lymph Node Metastasis in Bladder Urothelial Carcinoma. July 19, 2019

In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment. July 19, 2019

First-of-its-kind Rapid Autopsy Program Helps Reveal Deadly Disease’s Potential Vulnerabilities July 18, 2019

Predicting Short-Term Outcomes After Radical Cystectomy Based on Frailty. July 18, 2019

Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-term Outcomes With Dose Escalation. July 18, 2019

MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2. July 18, 2019

Predicting recurrence of nonmuscle-invasive bladder cancer (Ta-T1): A study based on 477 patients. July 17, 2019

Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect. July 17, 2019

The functions of microRNA-124 on bladder cancer. July 17, 2019

Seattle Genetics and Astellas Announce Submission of Biologics License Application to FDA for Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer July 16, 2019

The Correlation Between Bladder Cancer and Obesity, Overweight, Physical Inactivity, and Tobacco Use: An Ecological Study in Asian Countries. July 16, 2019

Role of gemcitabine and cisplatin as neoadjuvant chemotherapy in muscle invasive bladder cancer: Experience over the last decade. July 16, 2019

How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder. July 16, 2019

Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2). July 15, 2019

IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype. July 15, 2019

Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer. July 15, 2019

Taris Announces Positive Results of Phase 1b Trial of Tar-200 In Muscle Invasive Bladder Cancer July 12, 2019

Urinary expression of genes involved in DNA methylation and histone modification for diagnosis of bladder cancer in patients with asymptomatic microscopic haematuria. July 12, 2019

Page 8 of 303

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.